Gastrointestinal Cancer Excellence Forum

Gastrointestinal Cancer

Excellence Forum

Leaders in the field sharing authoritative insights and institutional best practices.

Jennifer Eads, MD, Abramson Cancer Center

Videos

Perioperative Chemotherapy Improved Survival Among Patients With Esophageal Adenocarcinoma

06/20/2024

Jennifer Eads, MD

Jennifer Eads, MD, comments on the results from the ESOPEC trial, which found perioperative chemotherapy improved survival for patients with resectable esophageal adenocarcinoma when compared with neoadjuvant chemoradiation.

Jennifer Eads, MD, comments on...

06/20/2024

Oncology

Martijn Meijerink, MD, PhD, Amsterdam UMC

Videos

Thermal Ablation Non-Inferior to Surgery for Patients With Smaller Colorectal Liver Metastases

06/19/2024

Martijn Meijerink, MD, PhD, shares results from the COLLISION trial which compared thermal ablation to surgical resection for patients with smaller colorectal liver metastases.

Martijn Meijerink, MD, PhD,...

06/19/2024

Oncology

Videos

Using Liquid Biopsy to Guide Post-Surgical Treatment Among Patients With Colon Cancer

11/16/2023

Featuring Sara Lonardi, MD

Sara Lonardi, MD, shares results from the PEGASUS trial which found post-surgical liquid biopsy may be used to guide the clinical management of patients with high-risk stage II or stage III colon cancer.

Sara Lonardi, MD, shares results...

11/16/2023

Oncology

Berend van der Wilk, MD, Erasmus University Medical Center

Videos

Active Surveillance After Neoadjuvant Chemoradiation for Select Patients With Esophageal Cancer

11/07/2023

Featuring Berend van der Wilk, MD

Featuring Berend van der Wilk, MD ...

Berend van der Wilk, MD, shares results from a phase 3 trial comparing active surveillance with surgery following neoadjuvant chemoradiotherapy for patients with esophageal cancer.

Berend van der Wilk, MD, shares...

11/07/2023

Oncology

Nataliya Uboha, MD, Carbone Cancer Center

Videos

Utilizing Biomarkers to Optimize Treatment for Upper Gastrointestinal Cancers

09/29/2023

Featuring Nataliya Uboha, MD, PhD

Featuring Nataliya Uboha, MD, PhD ...

At the Great Debates & Updates in Gastrointestinal Malignancies meeting, Nataliya Uboha, MD, PhD, discusses the use of biomakers to choose the best treatment for patients with upper GI cancers.

At the Great Debates & Updates...

09/29/2023

Oncology

Videos

Anti-Emesis For Patients With Gastrointestinal Cancers

08/24/2023

Featuring Matti Aapro, MD

At the 2023 World Congress on Gastrointesinal Cancers, Matti Aapro, MD, discusses how to best address emesis among patients with gastrointestinal cancers.

At the 2023 World Congress on...

08/24/2023

Oncology

Videos

Addition of Trastuzumab to Perioperative Chemotherapy Improved Response Rates Among Patients with HER2-Positive Gastric or Gastroesophageal Junction Cancer

08/11/2023

Featuring Anna Wagner, MD

At the 2023 World Congress on Gastrointestinal Cancers, Anna Wagner, MD, discusses the addition of trastuzumab to perioperative chemotherapy for patients with HER2-positive gastric or gastroesophageal junction cancer.

At the 2023 World Congress on...

08/11/2023

Oncology

Videos

Targeting KRAS in Gastrointestinal Cancers

07/14/2023

At the 2023 World Congress on Gastrointestinal Cancers, John Strickler, MD, reviews the currently available and upcoming strategies in targeting KRAS in gastrointestinal cancers.

At the 2023 World Congress on...

07/14/2023

Oncology

Van Morris, MD, MD Anderson Cancer Center

Videos

Ipilimumab Added to Nivolumab Does Not Significantly Improve Survival Outcomes for Patients With Squamous Cell Carcinoma of the Anal Canal

07/13/2023

Featuring Van Morris, MD

At the 2023 World Congress on Gastrointestinal Cancers, Van Morris, MD, presented results from a phase 2 study evaluating the addition of ipilimumab to nivolumab for patients with previously treated, unresectable or metastatic squamous cell...

At the 2023 World Congress on...

07/13/2023

Oncology

Lucjan Wyrwicz, MD, Maria Sklodowska Curie National Cancer Research Institute

Videos

Continued Benefit From Pembrolizumab Plus Chemotherapy in Later-Line Therapy for Patients With Advanced, HER2-Negative Gastric/Gastroesophageal Junction Adenocarcinoma

07/12/2023

Featuring Lucjan Wyrwicz, MD

At the 2023 World Congress on Gastrointestinal Cancers, Lucjan Wyrwicz discusses the extended benefit of pembrolizumab plus chemotherapy when evaluating outcomes on next-line therapy for advanced HER2-negative, gastric/gastroesophageal...

At the 2023 World Congress on...

07/12/2023

Oncology

Section Editor

Ghassan Abou-Alfa, MD, MBA

Memorial Sloan Kettering Cancer Center, New York

Gastrointestinal Cancer Excellence Forum

Section Editor

Resources

Specialties

Events

Year Round Education

HMP Global Products